de Groen Max Pieter
Known title: DirectorCIK: 0001823512
Associated companies
Transaction History
| NTNX | ▲ Buy | Grant | 4,588 | $0 | 12/12/2025 | View on chart |
| NTNX | ▼ Sell | Open Market | 5,480,467 | $421.0M | 6/5/2025 | View on chart |
| NTNX | ▼ Sell | Other | 125,183 | — | 6/5/2025 | View on chart |
| NTNX | ▼ Sell | Open Market | 5,500,000 | $409.8M | 3/4/2025 | View on chart |
| NTNX | ▼ Sell | Other | 393,097 | — | 3/4/2025 | View on chart |
| NTNX | ▲ Buy | Grant | 3,646 | $0 | 12/13/2024 | View on chart |
| NTNX | ▲ Buy | Option Exercise | 16,854,032 | $0 | 7/22/2024 | View on chart |
| NTNX | ▲ Buy | Grant | 6,088 | $0 | 12/8/2023 | View on chart |
| NTNX | ▲ Buy | Grant | 8,682 | $0 | 12/9/2022 | View on chart |
| NTNX | ▲ Buy | Grant | 7,365 | $0 | 12/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Nutanix Stock Underperforms Market Amid Broker Analysis
Nutanix shares have recently declined more sharply than the broader market, drawing attention from financial analysts. Recent broker reports suggest the stock is a focus for investment strategies, while comparisons with peers like MongoDB and Google highlight its position among value-oriented tech names. The company's trailing P/E of 12.7 and average analyst target of $77.79 provide context for these ongoing discussions.
Nutanix Stock Underperforms Market Amid Broker Analysis. Nutanix shares have recently declined more sharply than the broader market, drawing attention from financial analysts. Recent broker reports suggest the stock is a focus for investment strategies, while comparisons with peers like MongoDB and Google highlight its position among value-oriented tech names. The company's trailing P/E of 12.7 and average analyst target of $77.79 provide context for these ongoing discussions.